top
Search terms
Results 1 - 10 of 20 - ordered by :
Pages: 1 2
Ehjournal

While the former focused on individuals considered healthy, the latter was designed to avoid future events in those who already had coronary artery disease, myocardial infarction, or stroke.1 ...

European Heart Journal, Lüscher, Thomas F.

Date : 14/06/2017 Item size : 220664 bytes
Ehjournal

Age is an obvious risk factor, with overwhelming weight in all risk scores.1 Recent basic research showed that ageing is a genetic process facilitated by some genes such as those coding for the ...

European Heart Journal, Lüscher, Thomas F.

Date : 21/05/2017 Item size : 4411 bytes
Ehjournal

Methods and results Mortality, renal function, serum SDMA and HDL-cholesterol (HDL-C) were assessed in the LURIC study including 3310 subjects undergoing coronary angiography. Introduction ...

European Heart Journal, Zewinger, Stephen, Kleber, Marcus E., Rohrer, Lucia, Lehmann, Marlene, Triem, Sarah, Jennings, Richard T., Petrakis, Ioannis, Dressel, Alexander, Lepper, Philipp M., ...

Date : 21/05/2017 Item size : 424117 bytes
Ehjournal

An important novel topic in prevention is highlighted by Thomas Münzel and colleagues from the Johannes Gutenberg University in Mainz, Germany in a subsequent two-part clinical review article ...

European Heart Journal, Lüscher, Thomas F.

Date : 21/02/2017 Item size : 207956 bytes
Ehjournal

On 12 June 1957, the US Surgeon General Leroy E. Burney declared that the evidence suggested a causal link between smoking and lung cancer and heart disease. Ever since then, smoking cessation has ...

European Heart Journal, Lüscher, Thomas F.

Date : 01/08/2016 Item size : 185179 bytes
Ehjournal

[...]in coronary artery disease, not only lipids matter, but inflammation is about to become a major therapeutic target.4 Inflammation involves cellular and humoral factors.5,6 Thus, knowledge of ...

European Heart Journal, Lüscher, Thomas F.

Date : 14/03/2016 Item size : 161003 bytes
Ehjournal

[...]in coronary artery disease, not only lipids matter, but inflammation is about to become a major therapeutic target.4 Inflammation involves cellular and humoral factors.5,6 Thus, knowledge of ...

European Heart Journal, Lüscher, Thomas F.

Date : 14/03/2016 Item size : 188455 bytes
Ehjournal

Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors are a new class of drugs able to decrease LDL-C by 5070% when administered either as a monotherapy or on a background with statins.46 ...

European Heart Journal, Lüscher, Thomas F.

Date : 21/09/2015
Ehjournal

Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors are a new class of drugs able to decrease LDL-C by 5070% when administered either as a monotherapy or on a background with statins.46 ...

European Heart Journal, Lüscher, Thomas F.

Date : 21/09/2015 Item size : 220026 bytes
Ehjournal

[...]congenital heart disease, either in the young or in adults, often leads to pump failure and death.6 This issue begins with a Current Opinion article entitled Should extensive myocardial ...

European Heart Journal, Lüscher, Thomas F.

Date : 07/09/2015 Item size : 4411 bytes